Hydroxytoluic Acid

Hydroxytoluic Acid

SCHEMBL25756

Cc1cccc(C(=O)O)c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 1.00
KDM4E B2RXH2 4/20 1.00
HPGD P15428 3/20 1.00
HSD17B10 Q99714 2/20 1.00
CYP3A4 P08684 2/20 0.75
CYP2C9 P11712 2/20 0.75
KMT2A Q03164 2/20 0.75
ALB P02768 1/20 0.57
MMP2 P08253 1/20 0.57
MYC P01106 1/20 0.57
TRPA1 O75762 2/20 0.55
NAPRT Q6XQN6 2/20 0.55
MEN1 O00255 1/20 0.55
AKR1B10 O60218 1/20 0.55
ABCB11 O95342 1/20 0.55
DHFR P00374 1/20 0.55
LMNA P02545 1/20 0.55
MPO P05164 1/20 0.55
CYP1A2 P05177 1/20 0.55
CHRM1 P11229 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydroxytoluic Acid SCHEMBL29499765 1.00 ALDH1A1 (1.00) ALDH1A1KDM4EHPGDHSD17B10CYP3A4
Hydroxytoluic Acid SCHEMBL8352264 1.00 ALDH1A1 (1.00) ALDH1A1KDM4EHPGDHSD17B10CYP3A4
Hydroxytoluic Acid SCHEMBL28037743 1.00 ALDH1A1 (1.00) ALDH1A1KDM4EHPGDHSD17B10CYP3A4
Hydroxytoluic Acid SCHEMBL11527547 0.98 ALDH1A1 (0.96) ALDH1A1KDM4EHPGDHSD17B10CYP3A4
Hydroxytoluic Acid SCHEMBL31174935 0.98 ALDH1A1 (0.96) ALDH1A1KDM4EHPGDHSD17B10CYP3A4
Hydroxytoluic Acid SCHEMBL25338040 0.98 ALDH1A1 (0.96) ALDH1A1KDM4EHPGDHSD17B10CYP3A4
Hydroxytoluic Acid SCHEMBL30538825 0.98 ALDH1A1 (0.96) ALDH1A1KDM4EHPGDHSD17B10CYP3A4
Hydroxytoluic Acid SCHEMBL25337502 0.98 ALDH1A1 (0.96) ALDH1A1KDM4EHPGDHSD17B10CYP3A4
Hydroxytoluic Acid SCHEMBL238307 0.98 ALDH1A1 (0.96) ALDH1A1KDM4EHPGDHSD17B10CYP3A4
Hydroxytoluic Acid SCHEMBL622892 0.98 ALDH1A1 (0.96) ALDH1A1KDM4EHPGDHSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 20160 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122060373-A Epoxy-based multifunctional protective coating with enhanced azole bridging two-dimensional organic framework, and preparation method and application thereof 中国科学院宁波材料技术与工程研究所 2026-05-19 CN claimed
US-12629393-B2 Pharmaceutical composition for preventing or treating osteoarthritis KOLON LIFE SCIENCE, INC. (KR) 2026-05-19 US claimed
WO-2026101221-A1 NOVEL COMPOUND 아주대학교 산학협력단 2026-05-15 WO claimed
WO-2026099270-A1 BIODEGRADABLE UV ABSORBERS AND USES THEREOF II BASF SE (DE) 2026-05-15 WO claimed
WO-2026101215-A1 COMPOSITION FOR INHIBITING HEPATITIS B VIRUS (HBV) PROLIFERATION 아주대학교 산학협력단 2026-05-15 WO claimed
WO-2026100969-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SARCOPENIA 아주대학교 산학협력단 2026-05-15 WO claimed
WO-2026101222-A1 NOVEL COMPOUND 아주대학교 산학협력단 2026-05-15 WO claimed
WO-2026101218-A1 NOVEL COMPOUND AND COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR INHIBITING HEPATITIS B VIRUS (HBV) PROLIFERATION 아주대학교 산학협력단 2026-05-15 WO claimed
EP-3720563-B9 ORAL CARE COMPOSITIONS KENVUE BRANDS LLC (US) 2026-05-06 EP claimed
EP-4327813-B1 COADMINISTRATION OF MIRODENAFIL WITH CORT-108297 FOR PREVENTING AND TREATING DEMENTIA ARIBIO CO LTD (KR) 2026-04-08 EP claimed
EP-0028407-B1 PREPARATION OF 5-(HALOPHENYL)SALICYLIC ACID COMPOUNDS MERCK & CO. INC. (US) 1983-09-07 EP claimed
US-4374671-A CONTAINING ZINC OXIDE, A SALICYCLIC ACID AND A METAL SISLICATE FUJI PHOTO FILM CO.LTD. (JP) 1983-02-22 US claimed
US-4347245-A Spironolactone-containing composition and use thereof SHAPIRO GERMAN 1982-08-31 US claimed
EP-0039207-A1 Process for dyeing polyolefin fibre materials SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-11-04 EP claimed
EP-0036534-A1 An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant INTERx RESEARCH CORPORATION (US) 1981-09-30 EP claimed
EP-0036145-A1 An orally administered drug form comprising a polar bioactive agent and an adjuvant INTERx RESEARCH CORPORATION (US) 1981-09-23 EP claimed
EP-0035770-A2 An orally administered drug form comprising a glycosidic antibiotic and an adjuvant INTERx RESEARCH CORPORATION (US) 1981-09-16 EP claimed
EP-0031561-A2 A rectally administered suppository comprising a drug and an adjuvant MERCK & CO. INC. (US) 1981-07-08 EP claimed
US-4159208-A REACTING ALKALI METAL SALT OF AN AROMATIC CARBOXYLIC ACID AND A METAL SALT IN THE PRESENCE OF CLAY AND ALUMINUM COMPOUND FUJI PHOTO FILM CO., LTD. (JP) 1979-06-26 US claimed
US-4112115-A Therapy of leg muscle cramps COGHLAN CHARLES C 1978-09-05 US claimed